Iovance Biotherapeutics Inc (IOVA)

NASDAQ HEALTHCARE
$3.43 -0.29% RSI 43 Neutral Add Alert

Moving Averages

SMA 200
$2.60
Price above

Company Profile

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The company is headquartered in San Carlos, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$1.65B
P/E Ratio
None
EPS
$-1.09
Beta
0.764
Dividend Yield
0.00%
52-Week High
$5.63
52-Week Low
$1.64

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 54.0
VRTX
Vertex Pharmaceuticals Inc
RSI 37.0
CRSP
CRISPR Therapeutics AG
RSI 46.0
MRNA
Moderna Inc
RSI 35.0
VKTX
Viking Therapeutics Inc
RSI 39.0
SRPT
Sarepta Therapeutics Inc
RSI 50.0

Data last updated: April 11, 2026 at 2:08 AM EDT

Track IOVA for free

Get e-mail RSI alerts when Iovance Biotherapeutics Inc enters oversold or overbought territory. Free forever.

Add Alert